J. Cornier – Pharmaceutical Nanotechnology (2017)

Автор: J. Cornier
Название книги: Pharmaceutical Nanotechnology (2017)
Формат: PDF
Жанр: Медицина
Страницы: 787
Качество: Изначально компьютерное, E-book

With its focus on concrete methods and recent advances in applying nanotechnology to develop new drug therapies and medical diagnostics, this book provides an overall picture of the field, from the fundamentals of nanopharmacy with the characterisation and manufacturing methods to the role of nanoparticles and substances. Actual examples of utilization include drug development issues, translation to the clinic, market prospects, and industrial commercialization aspects. The applications described are taken from cancer treatment as well as other major therapeutic areas, such as infectious diseases and dermatology. An in-depth discussion on safety, regulatory, and societal aspects rounds off the book.
Written by a top team of editors and authors composed of the leading experts in Europe and the USA who have pioneered the field of nanopharmacy!

Albert Einstein once remarked: “Look deep into nature, and then you will understand
everything better.” Beginning with the idea that most people would not
believe in, nanotechnology has allowed us – literally – to look deep into the
functioning of biological mechanisms at molecular level and thereby define new
pathways for diagnosis and treatment of human disease. The nanotechnologybased
production of pharmaceuticals therefore has the potential to revolutionize
the treatment of human disease, facilitate changes in future healthcare systems
by enabling more personalized, predictive, preventive, regenerative, and even
remote (tele)medicine, and has a major impact on the survival of the human
race.
The book gives a thorough overview of the science and technology in the
nanopharmacy spectrum worldwide, and it also clearly highlights the research
requirements that Europe needs to undertake during the next decade if it is to
achieve invaluable breakthroughs in this fascinating field of nanopharmacy –
breakthroughs that will enable Europe to place itself among the top-ranking
competitive industrial regions in the world.
This is because nanotechnologies provide the tools for analysis and manipulation
of biological processes at the nanoscale, which is where diseases take root
and progress. The result is an increasingly better understanding of the molecular
biology of disease leading to new targets for more specific and earlier diagnostic
and therapeutic strategies.
This publication – which gives me genuine pleasure to introduce to you – is
perhaps the first time that Europe and the wider world have a unique opportunity.
This is both to assess the current state of the art and to provide the larger
nanomedicine community with new resources and strategies. It will make the
best of European and international innovation so as to generate a highly competitive
industrial sector. At the forefront is the very latest thinking in fundamental
research, characterization and safety issues of nanotechnology as applied to the
development of new drugs and treatments for medicine. This will help to meet
the enormous challenge of bringing new innovative, safe, and cost-effective
products to the patient in as short a time frame as possible. There is strong
emphasis on patient needs and concerns, including personalized approaches that
will make for new, efficient, and effective solutions for healthcare. Applications of nanotechnology for healthcare perhaps best exemplify how
interdisciplinary research is vital for future success. This is because all disciplines
and their stakeholders are represented in this work: beginning with the laboratory-
based scientists and including regulators, representatives from industry,
and most important of all representatives from society at large. All play an equal
part in delivering the appropriate benefits at the right time at the right price to
the right patient.
Only collaborations, such as those represented in this publication, will bring
new discoveries from science into products that generate greater economic value
through more rapid societal use. It is literally the attention to such small details
that can make this happen, for Albert Einstein also remarked: “Whoever is careless
with the truth in small matters cannot be trusted with important matters.”1)
This publication is a great initiative and will give an impetus to the entire
nanopharmacy community in Europe. For this reason, I believe that this book
should find a large distribution facilitating a broad debate between all policymaking
bodies and research institutes in Europe